I had one dose before they took it off the market. When it came back on the
market they had changed the protocol and I no longer qualify. I take Rebif and
I am pretty much stable on that. I still have attacks but they are less severe
and I can tolerate the drugso according to the protoc
*Hi Wim, *
**
*It's a monoclonal antibody and yes it is used successfully in MS patients.
I don't think that it would be of use to a patient who has had a TM attack.
*
**
*I use a monoclonal antibody called Rituximab, but I have NMO ,which means
that I have recurrent episodes of LETM (Longitudina
Is there anyone who has expirence with this new kind of drug. It is defeloped
for MS but what good is for that group, sometimes helps for TM patients.
Wim from Holland.
_
Nieuws, entertainment en de laatste roddels. Je vind het